CASPOFUNGIN FOR INJECTION
Google image searchProduct monograph
Active ingredient
caspofungin (caspofungin acetate), 50 MG/VIAL
DIN: 02486989
Dosage form(s): POWDER FOR SOLUTION
Route(s) of administration: INTRAVENOUS
Schedule: Prescription
Company: FRESENIUS KABI CANADA LTD
Date: 27-JAN-2020
ATC:
- J02 — ANTIMYCOTICS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J02A — ANTIMYCOTICS FOR SYSTEMIC USE (ATC, ATC/DDD)
- J02AX — Other antimycotics for systemic use (ATC, ATC/DDD)
- J02AX04 — CASPOFUNGIN (ATC/DDD)
Reference brand drug: Cancidas
Pharmaceutical standard: MFR